Indivior launches $175M accelerated share repurchase with Barclays

Indivior Pharmaceuticals, Inc.

Initial prepayment of $175M; received 3,717,473 shares from Barclays.
Final share count based on VWAP during term; settlement by June 22, 2026.
Part of existing $400M buyback program; $100M remains for future repurchases.
Company reaffirms prior financial guidance; ASR reflects confidence in strategy.

item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001625297-26-000021
form_type: 8-K
ticker: INDV
cik: 0001625297
company_name: Indivior Pharmaceuticals, Inc.
filed_at: 2026-05-04T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.609182+00:00
generated_at: 2026-05-14T23:55:18.476386+00:00
sec_items: ["7.01", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001625297-26-000021
json_url: https://secwatch.observer/filing/0001625297-26-000021.json
markdown_url: https://secwatch.observer/filing/0001625297-26-000021.md
text_url: https://secwatch.observer/filing/0001625297-26-000021.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/0001625297-26-000021-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/indv-20260504.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001625297-26-000021

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.